Bank of New York Mellon’s Vor Biopharma VOR Stock Holding History

Bank of New York Mellon’s Portfolio VOR Stock Details VOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.8M	Buy	+97,722	New	+$1.48M	﹤0.01%	3007
2024 Q2	–	Sell	-5,228	Closed	-$248K	–	4270
2024 Q1	$248K	Sell	5,228 -182	-3%	-$7.99K	﹤0.01%	3862
2023 Q4	$243K	Hold	5,410	–	–	﹤0.01%	3885
2023 Q3	$229K	Hold	5,410	–	–	﹤0.01%	3912
2023 Q2	$334K	Buy	5,410 +4,798	+784%	+$438K	﹤0.01%	3785
2023 Q1	$65.9K	Hold	612	–	–	﹤0.01%	4142
2022 Q4	$81.4K	Buy	+612	New	+$60.6K	﹤0.01%	4156
2022 Q2	–	Sell	-2,769	Closed	-$335K	–	4707
2022 Q1	$335K	Sell	2,769 -78	-3%	-$13.3K	﹤0.01%	3953
2021 Q4	$662K	Buy	2,847 +234	+9%	+$67.5K	﹤0.01%	3624
2021 Q3	$819K	Buy	2,613 +915	+54%	+$272K	﹤0.01%	3515
2021 Q2	$633K	Buy	1,698 +191	+13%	+$94.2K	﹤0.01%	3658
2021 Q1	$1.3M	Buy	+1,507	New	+$1.28M	﹤0.01%	3187

Other funds holding VOR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NFT

Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

VIA

Virtus Investment Advisers Hartford, Connecticut $429M AUM 52.52% 1-Year Est. Return

Bank of New York Mellon's VOR Position: Q2 2026 in Review

Bank of New York Mellon opened a new position in Vor Biopharma (VOR) in Q2 2026: 97,722 shares worth $1.8M. The stake represents ﹤0.01% of the portfolio and ranks #3007 among its holdings. This is a return to the name: Bank of New York Mellon previously reported a position in VOR as recently as Q1 2024.

Bank of New York Mellon first reported a position in VOR in Q1 2021 and has held it in 12 quarters since. 29 funds tracked by Wall St. Rank hold VOR as of Q2 2026.

Bank of New York Mellon held 97,722 shares of Vor Biopharma worth $1.8M as of Q2 2026.
Vor Biopharma was a new Bank of New York Mellon position in Q2 2026.
Vor Biopharma made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #3007 holding.
Bank of New York Mellon first reported a position in Vor Biopharma in Q1 2021 and has held it in 12 quarters since.
29 funds tracked by Wall St. Rank held Vor Biopharma as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.